Debt-to-equity in % of MediXall Group, Inc. from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
MediXall Group, Inc. quarterly Debt-to-equity history and change rate from Q3 2019 to Q3 2024.
  • MediXall Group, Inc. Debt-to-equity for the quarter ending 30 Sep 2024 was -104%, a 8.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

MediXall Group, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 -104% +10% +8.5% 30 Sep 2024
Q2 2024 -104% +15% +12% 30 Jun 2024
Q1 2024 -106% +23% +18% 31 Mar 2024
Q4 2023 -108% +39% +26% 31 Dec 2023
Q3 2023 -113% +66% +37% 30 Sep 2023
Q2 2023 -119% +167% +58% 30 Jun 2023
Q1 2023 -129% +850% +87% 31 Mar 2023
Q4 2022 -147% -577% -134% 31 Dec 2022
Q3 2022 -180% -431% -171% 30 Sep 2022
Q2 2022 -286% -442% -283% 30 Jun 2022
Q1 2022 -979% -1121% -786% 31 Mar 2022
Q4 2021 430% +256% +147% 31 Dec 2021
Q3 2021 251% +120% +92% 30 Sep 2021
Q2 2021 156% -14% -8% 30 Jun 2021
Q1 2021 143% -50% -26% 31 Mar 2021
Q4 2020 174% +57% +49% 31 Dec 2020
Q3 2020 131% +48% +58% 30 Sep 2020
Q2 2020 170% 30 Jun 2020
Q1 2020 193% 31 Mar 2020
Q4 2019 117% 31 Dec 2019
Q3 2019 83% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.